MOSCHETTA, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 13.451
AS - Asia 5.589
EU - Europa 4.120
SA - Sud America 1.635
AF - Africa 329
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 5
Totale 25.140
Nazione #
US - Stati Uniti d'America 13.238
SG - Singapore 2.299
BR - Brasile 1.325
CN - Cina 1.267
IT - Italia 973
HK - Hong Kong 696
SE - Svezia 624
RU - Federazione Russa 564
DE - Germania 470
VN - Vietnam 419
FI - Finlandia 317
FR - Francia 307
GB - Regno Unito 298
UA - Ucraina 220
IN - India 176
CI - Costa d'Avorio 141
BD - Bangladesh 136
ID - Indonesia 110
AR - Argentina 100
CA - Canada 99
IQ - Iraq 80
NL - Olanda 70
TR - Turchia 69
MX - Messico 67
ZA - Sudafrica 63
PK - Pakistan 49
EC - Ecuador 48
JP - Giappone 43
CO - Colombia 42
SA - Arabia Saudita 42
VE - Venezuela 41
PL - Polonia 40
IE - Irlanda 38
AT - Austria 36
BE - Belgio 36
ES - Italia 34
UZ - Uzbekistan 29
MA - Marocco 26
PY - Paraguay 24
PH - Filippine 23
CL - Cile 21
MY - Malesia 19
KE - Kenya 18
PE - Perù 18
TN - Tunisia 18
LT - Lituania 17
CZ - Repubblica Ceca 16
EG - Egitto 15
JO - Giordania 14
KR - Corea 14
IL - Israele 13
AU - Australia 11
DZ - Algeria 11
NP - Nepal 10
ET - Etiopia 9
JM - Giamaica 9
AE - Emirati Arabi Uniti 8
AL - Albania 8
CH - Svizzera 8
PS - Palestinian Territory 8
BO - Bolivia 7
DO - Repubblica Dominicana 7
KZ - Kazakistan 7
LB - Libano 7
OM - Oman 7
UY - Uruguay 7
PA - Panama 6
PT - Portogallo 6
AO - Angola 5
AZ - Azerbaigian 5
BH - Bahrain 5
GR - Grecia 5
HN - Honduras 5
IR - Iran 5
NI - Nicaragua 5
GT - Guatemala 4
KW - Kuwait 4
RO - Romania 4
RS - Serbia 4
TT - Trinidad e Tobago 4
BY - Bielorussia 3
GE - Georgia 3
HU - Ungheria 3
KG - Kirghizistan 3
SI - Slovenia 3
SN - Senegal 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
BJ - Benin 2
BN - Brunei Darussalam 2
CR - Costa Rica 2
CV - Capo Verde 2
EU - Europa 2
HR - Croazia 2
IM - Isola di Man 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
LY - Libia 2
MD - Moldavia 2
Totale 25.101
Città #
Fairfield 1.624
Ashburn 1.375
Singapore 1.204
Woodbridge 1.130
Houston 812
Chandler 727
San Jose 700
Hong Kong 688
Seattle 604
Cambridge 594
Wilmington 530
Nyköping 488
Jacksonville 477
Ann Arbor 461
Beijing 376
Bari 263
New York 228
Lauterbourg 201
Lawrence 189
Roxbury 187
Nanjing 182
Los Angeles 181
Helsinki 145
Abidjan 141
Dearborn 125
Dallas 124
Ho Chi Minh City 122
Des Moines 111
Council Bluffs 110
Munich 101
Boardman 98
Inglewood 97
Santa Clara 97
Buffalo 93
Hanoi 91
São Paulo 91
Princeton 88
Brooklyn 84
Chicago 79
Jakarta 77
San Diego 77
London 64
Falkenstein 58
Shenyang 49
Hebei 43
Nuremberg 42
Frankfurt am Main 40
Montreal 40
Rio de Janeiro 39
Moscow 38
Dublin 37
Dong Ket 34
Turku 34
Brussels 33
Tokyo 33
Jiaxing 32
Nanchang 32
Rome 31
Belo Horizonte 30
Denver 30
Guangzhou 30
San Giovanni Teatino 30
Warsaw 30
Johannesburg 28
Chennai 27
Orem 27
Salt Lake City 26
Atlanta 24
Baghdad 24
Cressa 24
Curitiba 24
Paris 24
San Francisco 24
Tashkent 24
Dhaka 23
Istanbul 23
Porto Alegre 23
Tianjin 23
Toronto 23
Brasília 22
Da Nang 22
Phoenix 22
Poplar 22
Columbus 21
Changsha 20
Hefei 19
Indianapolis 19
Mexico City 19
Boston 18
Lahore 18
The Dalles 18
Haiphong 17
Manchester 17
Nairobi 17
Naples 17
Pescara 17
Redwood City 17
Fortaleza 16
Kunming 16
Milan 16
Totale 16.782
Nome #
Metabolic aspects in NAFLD, NASH and hepatocellular carcinoma: the role of PGC1 coactivators 249
Long-term Administration of Nuclear Bile Acid Receptor FXR Agonist Prevents Spontaneous Hepatocarcinogenesis in Abcb4-/- Mice 241
TRIM8 restores p53 tumour suppressor function by blunting N-MYC activity in chemo-resistant tumours 197
Genes and miRNA expression signatures in peripheral blood mononuclear cells in healthy subjects and patients with metabolic syndrome after acute intake of extra virgin olive oil 190
Uncoupling FoxO3A mitochondrial and nuclear functions in cancer cells undergoing metabolic stress and chemotherapy. 189
Deletion of Stearoyl-CoA Desaturase-1 From the Intestinal Epithelium Promotes Inflammation and Tumorigenesis, Reversed by Dietary Oleate 186
Adenomatous polyposis coli (APC)-induced apoptosis of HT29 colorectal cancer cells depends on mitochondrial oxidative metabolism 184
Hepatic microRNA Expression by PGC-1α and PGC-1β in the Mouse 183
Basolateral Ca2+-dependent K+-channels play a key role in Cl- secretion induced by taurodeoxycholate from colon mucosa 181
Integrative miRNA and Whole-Genome Analyses of Epicardial Adipose Tissue in Patients with Coronary Atherosclerosis 179
Role of oleic acid in the gut-liver axis: From diet to the regulation of its synthesis via Stearoyl-CoA desaturase 1 (SCD1) 179
Extra virgin olive oil: Lesson from nutrigenomics 179
Extra-virgin olive oil from Apulian cultivars and intestinal inflammation 177
Is hepatic lipogenesis fundamental for NAFLD/NASH? A focus on the nuclear receptor coactivator PGC-1β 175
The gut-liver axis in hepatocarcinoma: a focus on the nuclear receptor FXR and the enterokine FGF19 170
Nuclear receptor FXR, bile acids and liver damage: Introducing the progressive familial intrahepatic cholestasis with FXR mutations 170
Clustering nuclear receptors in liver regeneration identifies candidate modulators of hepatocyte proliferation and hepatocarcinoma. 168
Sindrome metabolica e lavoro 168
Atherosclerosis: lessons from LXR and the intestine. 164
Down-regulation of the LXR transcriptome provides the requisite cholesterol levels to proliferating hepatocytes 163
Hepatic peroxisome proliferator‐activated receptor γ coactivator 1β drives mitochondrial and anabolic signatures that contribute to hepatocellular carcinoma progression in mice 163
PGC-1α induced browning promotes involution and inhibits lactation in mammary glands 160
Uridine and pyruvate protect T cells’ proliferative capacity from mitochondrial toxic antibiotics: a clinical pilot study 159
Activation of LXRs prevents bile acid toxicity and cholestasis in female mice 157
Biliary Phospholipids Sustain Enterocyte Proliferation and Intestinal Tumor Progression via Nuclear Receptor Lrh1 in mice 155
Nuclear receptors expression chart in peripheral blood mononuclear cells identifies patients with Metabolic Syndrome. 152
The European accreditation of Istituto Tumori Giovanni Paolo II of Bari 152
Bile acids lower triglyceride levels via a pathway involving FXR, SHP and SREBP1c 148
A phylogenetic survey of biliary lipids in vertebrates 147
Hepatic-specific PPARa-FGF21 action in NAFLD 145
Pathophysiology of cholesterol gallstone disease 144
Modulation of cholesterol crystallization in bile. Implications for non-surgical treatment of cholesterol gallstone disease. 144
The Intestinal Nuclear Receptor Signature With Epithelial Localization Patterns and Expression Modulation in Tumors 143
A Novel Protective Role for FXR against Inflammasome Activation and Endotoxemia 142
PGC-1β Induces Susceptibility To Acetaminophen-Driven Acute Liver Failure 141
Effect of hydrosoluble vitamin E on erythrocyte membrane lipid composition in patients with advanced cirrhosis: An open-label pilot trial. 140
Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis 140
The "hemolysis model" for the study of cyto-toxicity and cyto-protection by bile salts and phospholipids 138
Mitochondrial function - gatekeeper of intestinal epithelial cell homeostasis 138
Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23 137
Casting a shadow on liver X receptor-mediated atheroprotection: is LXRβ to blame? 136
Expression and localisation of insulin receptor substrate 2 in normal intestine and colorectal tumours. Regulation by intestine-specific transcription factor CDX2 136
let-7e downregulation characterizes early phase colonic adenoma in APCMin/+ mice and human FAP subjects 136
Parallel intestinal and liver injury during early cholestasis in the rat: modulation by bile salts and antioxidants 134
A translational view on the biliary lipid secretory network 134
The emerging discipline of precision cooking: a suitable tool for the precision nutrition 134
Relationship Between Oral Lesions and Severe SARS-CoV-2 Infection in Intensive Care Unit Patients 133
Aminotransferase activity in morbid and uncomplicated obesity: Predictive role of fasting insulin 133
FXR agonists and FGF15 reduce fecal bile acid excretion in a mouse model of bile acid malabsorption 132
Integrative genetic, epigenetic and pathological analysis of paraganglioma reveals complex dysregulation of NOTCH signaling 132
Intracoronary monocyte expression pattern and HDL subfractions after non-ST elevation myocardial infarction 132
The FXR-FGF19 Gut-Liver Axis as a Novel "hepatostat" 131
Neuron-derived orphan receptor 1 promotes proliferation of quiescent hepatocytes 131
Intestinal ecology in the metabolic syndrome 131
LXRs, SHP, and FXR in Prostate Cancer: Enemies or Ménage à Quatre With AR? 130
Uncoupling nuclear receptor LXR and cholesterol metabolism in cancer 127
Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease 127
Intestinal specific LXR activation stimulates reverse cholesterol transport and protects from atherosclerosis 127
Water handling and aquaporins in bile formation: recent advances and research trends 127
Master regulation of bile acid and xenobiotic metabolism via the FXR, PXR and CAR trio 126
Selective Activation of Nuclear Bile Acid Receptor FXR in the Intestine Protects Mice Against Cholestasis. 126
AST to Platelet Ratio Index (APRI) is an easy-to-use predictor score for cardiovascular risk in metabolic subjects 126
Primary sclerosing cholangitis: updates in diagnosis and therapy. 125
Pathways of cholesterol crystallization in model bile and native bile 125
Lipid metabolism in colon cancer: Role of Liver X Receptor (LXR) and Stearoyl-CoA Desaturase 1 (SCD1) 124
Lipid-sensing nuclear receptors in the pathophysiology and treatment of the metabolic syndrome 123
SEL1L, an UPR response protein, a potential marker of colonic cell transformation. 123
Enterocyte superoxide dismutase 2 deletion drives obesity 123
Effects of hydrophobic and hydrophilic bile salt mixtures on cholesterol crystallization in model biles 122
Liver X Receptors Inhibit Proliferation of Human Colorectal Cancer Cells and Growth of Intestinal Tumors in Mice 122
LA SINDROME METABOLICA NEGLI ADDETTI ALLA PESCA MARITTIMA 122
Extra virgin olive oil extracts modulate the inflammatory ability of murine dendritic cells based on their polyphenols pattern: Correlation between chemical composition and biological function 122
Nuclear receptors, intestinal architecture and colon cancer: an intriguing link 121
Asymmetric distribution of phosphatidylcholine and sphyngomyelin between micellar and vesicular phases: potential implication for canalicular bile formation 121
The Impact of Biologic Drugs on High-Density Lipoprotein Cholesterol Efflux Capacity in Rheumatoid Arthritis Patients 121
Intestinal FXR Activation via Transgenic Chimera or Chemical Agonism Prevents Colitis-Associated and Genetically-Induced Colon Cancer 120
Exploration of Inflammatory Bowel Disease in Mice: Chemically Induced Murine Models of Inflammatory Bowel Disease (IBD) 120
Welcoming Foxa2 in the bile acid entourage 120
Dimethyl fumarate ameliorates hepatic inflammation in alcohol related liver disease 119
Another one bites the gut: Nuclear receptor lrh-1 in intestinal regeneration and cancer 119
Preface: a special issue on nuclear receptors with a special view on the molecular basis of disease. 118
Nuclear receptors and cholesterol metabolism in the intestine 118
Nuclear bile acid receptor FXR as pharmacological target: are we there yet? 118
Intestinal nuclear receptors in HDL cholesterol metabolism. 118
Liver X Receptor Regulates Triglyceride Absorption Through Intestinal Down-regulation of Scavenger Receptor Class B, Type 1 118
Adhesion of platelets to colon cancer cells is necessary to promote tumor development in xenograft, genetic and inflammation models 118
Interleukins 1 beta and 6 induce functional alteration of rat colonic motility: an in vitro study 117
Taurodeoxycholate-induced intestinal injury is modulated by oxidative stress-dependent pre-conditioning like mechanisms 117
Identification of miR-9-5p as direct regulator of ABCA1 and HDL-driven reverse cholesterol transport in circulating CD14+ cells of patients with metabolic syndrome 117
Bile acids and colon cancer: Solving the puzzle with nuclear receptors 116
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis 115
Tissue-specific actions of FXR in metabolism and cancer. 115
A novel cell type-specific role of p38alpha in the control of autophagy and cell death in colorectal cancer cells 114
Linking transcription to physiology in lipidomics 114
Changes of gallbladder and gastric dynamics in patients with acute hepatitis A 113
Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X Receptor 113
Abdominal obesity negatively influences key metrics of reverse cholesterol transport 113
Hepatic‐specific Pgc‐1α ablation drives fibrosis in a MASH model 111
Bile Salt Hydrolase-Competent Probiotics in the Management of IBD: Unlocking the "Bile Acid Code" 110
Hepatic Niemann Pick C1-like 1: the canalicular side of the coin 110
Totale 14.013
Categoria #
all - tutte 109.770
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.770


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021122 0 0 0 0 0 0 0 0 0 0 0 122
2021/20221.581 144 186 31 65 58 189 50 90 113 124 234 297
2022/20232.099 328 223 137 156 222 300 17 254 339 22 51 50
2023/2024851 52 166 37 52 68 211 33 53 7 29 41 102
2024/20254.363 151 30 318 146 104 365 518 379 229 261 584 1.278
2025/20268.558 1.282 426 610 1.081 975 530 964 297 1.010 956 365 62
Totale 25.960